ASHLEIGH BROWN: Open Payments
NPI 1972931061 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 75 payments from 14 companies in 2025. Trend: 2023 $1,808 · 2024 $1,232 · 2025 $1,364
Food & beverage: $1,355Education: $9
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $492 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $144 |
| Otsuka America Pharmaceutical, Inc. | 8 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $109 |
| Supernus Pharmaceuticals, Inc. | 5 | $85 |
| Lundbeck LLC | 3 | $74 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| ABBVIE INC. | 3 | $53 |
| Alkermes, Inc. | 3 | $52 |
Products named: HETLIOZ, REXULTI, TRINTELLIX, CAPLYTA, Qelbree, Auvelity, AUSTEDO XR, VRAYLAR.
Industry payments across NC — which companies pay providers there.
